Exosens SAS Past Earnings Performance
Past criteria checks 3/6
Exosens SAS has been growing earnings at an average annual rate of 83.2%, while the Aerospace & Defense industry saw earnings growing at 24.4% annually. Revenues have been growing at an average rate of 22.1% per year. Exosens SAS's return on equity is 13%, and it has net margins of 12.9%.
Key information
83.16%
Earnings growth rate
121.63%
EPS growth rate
| Aerospace & Defense Industry Growth | 16.71% |
| Revenue growth rate | 22.05% |
| Return on equity | 12.97% |
| Net Margin | 12.91% |
| Next Earnings Update | 27 Oct 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Exosens SAS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 432 | 56 | 128 | 0 |
| 31 Mar 25 | 413 | 41 | 121 | 0 |
| 31 Dec 24 | 394 | 26 | 115 | 0 |
| 30 Sep 24 | 374 | 14 | 108 | 0 |
| 30 Jun 24 | 354 | -3 | 104 | 0 |
| 31 Mar 24 | 323 | 2 | 94 | 0 |
| 31 Dec 23 | 292 | 7 | 85 | 0 |
| 31 Dec 22 | 201 | 1 | 65 | 0 |
| 31 Dec 21 | 166 | -149 | 58 | 0 |
| 31 Dec 20 | 150 | -16 | 53 | 0 |
Quality Earnings: H8Y has high quality earnings.
Growing Profit Margin: H8Y became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: H8Y has become profitable over the past 5 years, growing earnings by 83.2% per year.
Accelerating Growth: H8Y has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: H8Y has become profitable in the last year, making it difficult to compare its past year earnings growth to the Aerospace & Defense industry (25.7%).
Return on Equity
High ROE: H8Y's Return on Equity (13%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/01 19:38 |
| End of Day Share Price | 2025/08/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Exosens SAS is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Laurent Gelebart | BNP Paribas Exane |
| Charles Armitage | Citigroup Inc |
| David Perry | J.P. Morgan |